Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity
Shenqiu Wang(Memorial Sloan Kettering Cancer Center), Hans‐Guido Wendel(Memorial Sloan Kettering Cancer Center)
Cited by 33
Related Papers
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
|The Journal of Experimental Medicine|2011|114
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
|The Journal of Experimental Medicine|2014|33
Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
|Science Translational Medicine|2021|13
A Rapid Translational Immune Response Program in CD8 Memory T Lymphocytes
|The Journal of Immunology|2022|12
Abstract 3731: Epigenetic control of tumor cell killing by natural killer cells
|Cancer Research|2022|0